Imperial Valley News Center

Details

Washington, DC - The U.S. Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the U.S. The FDA’s regulations have not hindered or been a roadblock to the rollout of tests during this pandemic. Every action the FDA has taken during this public health emergency to address the COVID-19 pandemic has balanced the urgent need to make diagnostic tests available with providing a level of oversight that ensures accurate tests are being deployed.

Details

Washington, DC - Memorandum on Extending the Wind-Down Period for Deferred Enforced Departure for Liberians:

Details

Washington, DC - President Trump and Members of the Coronavirus Task Force in a Press Briefing:

Details

Washington, DC - Today, President Donald J. Trump announced his intent to nominate:

Details

Washington, DC - On April 1, 2015, by Executive Order 13694, the President declared a national emergency pursuant to the International Emergency Economic Powers Act (50 U.S.C. 1701 et seq.) to deal with the unusual and extraordinary threat to the national security, foreign policy, and economy of the United States constituted by the increasing prevalence and severity of malicious cyber‑enabled activities originating from, or directed by persons located, in whole or in substantial part, outside the United States.  On December 28, 2016, the President issued Executive Order 13757 to take additional steps to address the national emergency declared in Executive Order 13694.

Details

Washington, DC - Memorandum on Providing Federal Support for Governors’ Use of the National Guard to Respond to COVID-19:

  1. Proclamation on National Doctors Day, 2020
  2. President Trump in a Meeting with Supply Chain Distributors on COVID-19
  3. Letter from the Vice President to Hospital Administrators
  4. Linda Summers providing a glimpse into "The Great Awakening"
  • You are here:  
  • Home